Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

907 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
Yoshida A, Asanuma H, Sasaki H, Sanada S, Yamazaki S, Asano Y, Shinozaki Y, Mori H, Shimouchi A, Sano M, Asakura M, Minamino T, Takashima S, Sugimachi M, Mochizuki N, Kitakaze M. Yoshida A, et al. Among authors: minamino t. Cardiovasc Drugs Ther. 2012 Jun;26(3):217-26. doi: 10.1007/s10557-012-6381-5. Cardiovasc Drugs Ther. 2012. PMID: 22527618
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A, Minamino T, Asanuma H, Sanada S, Fujita M, Tsukamoto O, Wakeno M, Myoishi M, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Hirata A, et al. Among authors: minamino t. Cardiovasc Drugs Ther. 2005 Jan;19(1):33-40. doi: 10.1007/s10557-005-6895-1. Cardiovasc Drugs Ther. 2005. PMID: 15883754
A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart.
Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, Hirata A, Fujita M, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Tsukamoto O, et al. Among authors: minamino t. Biochem Biophys Res Commun. 2005 Dec 23;338(3):1460-6. doi: 10.1016/j.bbrc.2005.10.109. Epub 2005 Oct 26. Biochem Biophys Res Commun. 2005. PMID: 16271703
The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
Tsukamoto O, Minamino T, Sanada S, Okada K, Hirata A, Fujita M, Shintani Y, Yulin L, Asano Y, Takashima S, Yamasaki S, Tomoike H, Hori M, Kitakaze M. Tsukamoto O, et al. Among authors: minamino t. Cardiovasc Drugs Ther. 2006 Apr;20(2):93-102. doi: 10.1007/s10557-006-8130-0. Cardiovasc Drugs Ther. 2006. PMID: 16761190
Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, Wakeno M, Tsukamoto O, Okada K, Komamura K, Takashima S, Shinozaki Y, Mori H, Mochizuki N, Kitakaze M. Takahama H, et al. Among authors: minamino t. Cardiovasc Drugs Ther. 2006 Jun;20(3):159-65. doi: 10.1007/s10557-006-8285-8. Cardiovasc Drugs Ther. 2006. PMID: 16775664
An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Ihara M, Asanuma H, Yamazaki S, Kato H, Asano Y, Shinozaki Y, Mori H, Minamino T, Asakura M, Sugimachi M, Mochizuki N, Kitakaze M. Ihara M, et al. Among authors: minamino t. Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1287-97. doi: 10.1152/ajpheart.00835.2014. Epub 2015 Mar 6. Am J Physiol Heart Circ Physiol. 2015. PMID: 25747753 Free article.
Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts.
Asanuma H, Sanada S, Yoshitomi T, Sasaki H, Takahama H, Ihara M, Takahama H, Shinozaki Y, Mori H, Asakura M, Nakano A, Sugimachi M, Asano Y, Minamino T, Takashima S, Nagasaki Y, Kitakaze M. Asanuma H, et al. Among authors: minamino t. Cardiovasc Drugs Ther. 2017 Dec;31(5-6):501-510. doi: 10.1007/s10557-017-6758-6. Cardiovasc Drugs Ther. 2017. PMID: 29101507
907 results